Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alteplase vs Urokinase for Pleural Empyema
NCT01246453Phase 4Completed
- Sponsor
- Vall d'Hebron Research Institute
- Start
- Dec 2003
- Primary completion
- Dec 2010
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of tissue-plasminogen activator in pleural empyema, parapneumonic pleural effusion, sponsored by Vall d'Hebron Research Institute. Started Dec 2003; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
pleural empyemaparapneumonic pleural effusion
Beyond the preview
Go deeper on NCT01246453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01246453.